Trademark Search  /  IMMUNOSTASIS

IMMUNOSTASIS

○ Dead · Abandoned

U.S. federal trademark · Serial No. 97007239

Mark
IMMUNOSTASIS
Status
Abandoned
Serial Number
97007239
Filing Date
September 1, 2021
Class(es)
Class 005, Class 041, Class 042

Owner

Statera Biopharma, Inc.
03 · Fort Collins, CO, US

Goods & Services

Educational services, namely, conducting classes, seminars, conferences, and workshops and distributing printed course materials in conjunction therewith; providing on-line journals, namely, blogs in the medical, pharmaceutical and health fields

Pharmaceutical preparations and compounds for use in immune modulation, oncology, infectious diseases; pharmaceutical preparations for the treatment or prevention of immune-mediated diseases, Crohn's disease, multiple sclerosis, viral infections, HIV/AIDS, cancer, cell growth related disorders, cell proliferation related disorders, inflammatory diseases, ulcerative diseases, autoimmune diseases, autism, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; anti-infectives; anti-inflammatories; vaccines; pharmaceutical preparations and compounds for reducing side effects in cancer treatment; pharmaceutical preparations and compounds for stimulating the immune system in an immuno-compromised patient; dietetic substances for medical purposes, namely, nutritional, vitamin and mineral supplements

Pharmaceutical and therapeutics research and development services for systemically delivered, locally active immune balancing conjugates, small molecules and peptides; research and development of systemically delivered, locally active immune balancing conjugates, small molecules and peptides in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune balancing conjugates, small molecules and peptides in the field of human therapeutics; research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases with systemically delivered, locally active immune balancing conjugates, small molecules and peptides; pharmaceutical product development of systemically delivered, locally active immune balancing conjugates, small molecules and peptides

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "IMMUNOSTASIS" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.